AIM
AGIO icon

Aigen Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Aigen Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,915
Closed -$705K – 509
2025
Q4 		$705K Buy
+25,915
New +$909K 0.16% 189
2023
Q1 		– Sell
-9,814
Closed -$276K – 598
2022
Q4 		$276K Buy
+9,814
New +$277K 0.04% 380
2020
Q4 		– Sell
-23,112
Closed -$809K – 758
2020
Q3 		$809K Buy
+23,112
New +$1.01M 0.1% 307
2020
Q2 		– Sell
-22,114
Closed -$785K – 788
2020
Q1 		$785K Buy
22,114
+13,636
+161% +$630K 0.1% 282
2019
Q4 		$405K Buy
+8,478
New +$320K 0.07% 377

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Aigen Investment Management's AGIO Position: Q1 2026 in Review

Aigen Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 25,915 shares — an estimated $705K sold.

Aigen Investment Management first reported a position in AGIO in Q4 2019 and held it in 5 quarters. The position peaked at $809K in Q3 2020. 234 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Aigen Investment Management reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Aigen Investment Management sold 25,915 Agios Pharmaceuticals shares in Q1 2026, an estimated $705K.
  • Aigen Investment Management first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • Aigen Investment Management's Agios Pharmaceuticals position peaked at $809K in Q3 2020.
  • 234 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.